Kestra Advisory Services’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$589K Buy
33,760
+2,281
+7% +$39.8K ﹤0.01% 1845
2025
Q1
$396K Buy
+31,479
New +$396K ﹤0.01% 1975